SMS Pharmaceuticals receives non-exclusive licence to manufacture and supply Molnupiravir through… EP News Bureau Jan 22, 2022 The step has been taken to increase broad access of COVID-19 treatment in 105 Low- and Middle- Income Countries (LMICs)
